| ITG has received the Manufacturing License for Lu-177 n.c.a. |
| Monday, 23 January 2012 08:45 | |
|
As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the Lu-177 n.c.a. and has subsequently received the “Herstellungserlaubnis”. More than 15 reactors and accelerators in Europe, Australia, Africa, Russia and the FRM II form a network of irradiation facilities for ITG´s radioisotopes.
For further inquiries or if you would like to schedule a meeting with our representatives please contact:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
News
ITG and NTP Cooperation – Milestone in Global Security of Supply for Radioisotope IndustryPress Release - ITG Isotope Technologies Garching GmbH (ITG) - specialist in innovative radioisotopes - expands its nuclear reactor and...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |